Celastrol-type HSP90 modulators allow for potent cardioprotective effects
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 227, 8-19
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (344873)
- Mitacs
This publication has 46 references indexed in Scilit:
- Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial InfarctionJAMA Cardiology, 2017
- The HSP90 chaperone machineryNature Reviews Molecular Cell Biology, 2017
- Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the HeartCardiovascular Research, 2017
- Mutations Y493G and K546D in human HSP90 disrupt binding of celastrol and reduce interaction with Cdc37FEBS Open Bio, 2016
- Ischaemic conditioning and reperfusion injuryNature Reviews Cardiology, 2016
- Celastrol protects ischaemic myocardium through a heat shock response with up‐regulation of haeme oxygenase‐1British Journal of Pharmacology, 2014
- Myocardial ischemia-reperfusion injury: a neglected therapeutic targetJournal of Clinical Investigation, 2013
- Activation of Heat Shock and Antioxidant Responses by the Natural Product Celastrol: Transcriptional Signatures of a Thiol-targeted MoleculeMolecular Biology of the Cell, 2008
- Myocardial Reperfusion InjuryNew England Journal of Medicine, 2007
- Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction.Circulation, 1993